Recent Blog Posts

View Post: Insulin Aspart to treat insulin allergy - TuDiabetes - A Community ...
13 Nov 2009 by ThunderOwl  
Does anyone have info or personal experience with an insulin allergy? I have read that insulin aspart can be used with success for people with an insulin allergy. I have also read that there are highly purified forms of insulin that ...
View Blog: Discussion Forum - TuDiabetes - A Community... - http://tudiabetes.com/forum?feed=yes&xn_auth=no

---

View Post: Combining insulin with metformin or repaglinide in non-obese ...
9 Nov 2009
The researchers conclude that in non-obese patients with type 2 diabetes, biphasic insulin aspart 70/30 plus metformin and biphasic insulin aspart 70/30 plus repaglinide are both safe and effective means of glycaemic regulation, ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: Continuing metformin after insulin initiation - Diabetes Forums
11 Nov 2009 by foxl  
Total daily insulin dose and risk of hypoglycaemia were also similar in the two treatment groups. Weight gain was less with metformin plus biphasic insulin aspart 70/30 than with repaglinide plus biphasic insulin aspart 70/30 ...
View Blog: Diabetes Forums - http://www.diabetesforums.com/forum/

---

View Post: Diabetes Mellitus, Type 2 Clinical Trial: Comparison of NN5401 ...
4 Nov 2009
Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Both With or Without Metformin, With or Without DPP-4 Inhibitor, With or Without Pioglitazone in Subjects With Type 2 Diabetes (BOOST™: Intensify Premix 1)”. Condition Keyword(s): ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Diabetes Mellitus (DM)
15 Nov 2009 by spark  
A protein: not to be taken orally because it would be digested in the stomach by gastric acids; should be injected mostly subcutaneously; Ultra-rapid acting: onset of action within 15 minutes: insulin lispro/ Humalog; insulin aspart/ ...
View Blog: Pharmacy Technician's Study Notes - http://pharmatechtalk.blogspot.com/

---

View Post: Redesigned Assure Pro Blood Glucose Monitor Test Strips available ...
12 Nov 2009
Updated: 6/30/2009. NOVOLOG. Endocrine System > Diabetes. Insulin aspart (recombinant) 100 Units/mL; soln for SC inj, continuous subcutaneous insulin infusion (CSII), IV infusion; contains zinc, m-cresol. ...
View Blog: Latest articles from MPR - http://www.empr.com/

---

View Post: FDA Approves NovoLog(R) Labeling Update - PMD
16 Jul 2009
PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Diabetes patients taking NovoLog(®) (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration ...
View Blog: Latest articles from PMD - http://www.pmdcentral.com/

---

View Post: Using Insulin and Diabetes
13 Nov 2009 by Charles  
Insulin aspart is fast acting. You should eat a meal within ten mins of injecting it. Use each disposable needle just once and throw it away in a puncture-proof container. Keep the container of used needles away from children and pets. ...
View Blog: Intelli Weightloss - http://intelliweightloss.com/

---

View Post: Comparison of Three Insulin Regimens - N Engl J Med 2009 Oct 29 ...
5 Nov 2009
Researchers randomized 708 patients with type 2 diabetes who were taking metformin and a sulfonylurea (glycosylated hemoglobin [HbA1c] level, 7%–10%) to receive one of three insulin regimens, added to their oral drugs: ... Twice-daily biphasic insulin aspart (NovoMix 30); Thrice-daily prandial insulin aspart (NovoRapid). During the trial, if HbA1c levels remained higher than 6.5% despite insulin titration, sulfonylurea was stopped and a second insulin was added (3 ...
View Blog: Three.Word.Title - http://baoanh.posterous.com/

---

View Post: A Randomized Trial Comparing Continuous Subcutaneous Insulin ...
28 Jan 2008 by Weinzimer, SA, Ternand, C., Howard, C.,...  
OBJECTIVE—The safety and efficacy of insulin aspart continuous subcutaneous insulin infusion (CSII) was compared with that of insulin lispro CSII in children and adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS—Children and ...
View Blog: Diabetes Care Journal publish ahead of... - http://care.diabetesjournals.org/

---